PIRAMAL DESFLURANE (Piramal Critical Care Pty Ltd)
Product name
PIRAMAL DESFLURANE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
140 working days (255)
Active ingredients
desflurane
Registration type
New generic medicine
Indication
PIRAMAL DESFLURANE (inhalation bottle) is indicated as an inhalation agent for maintenance of anaesthesia. Desflurane is not recommended for mask induction of anaesthesia because of a high incidence of moderate to severe upper airway adverse events.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine